Beskrovnaya Oxana
Related Filers (1)
Other (2)
144
Thursday, 1/4/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/3/2024
Filing for proposed sale of securities under Rule 144
Ownership (18)
4
Thursday, 1/4/2024
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/12/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/16/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/20/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/13/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/14/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/15/2023
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/13/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/21/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/15/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/14/2022
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/14/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/22/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/18/2020
Dyne Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/16/2020
Dyne Therapeutics, Inc.: Initial statement of beneficial ownership of securities